E. Garret-Mayer

blunts oral squamous cancer development and dampens the functional expansion of myeloid-derived suppressor cells

Hong-gang Yu, Yongliang Zhang, Zihai Li, 2016 .

CD24 blunts oral squamous cancer development and dampens the functional expansion of myeloid-derived suppressor cells

Hong-gang Yu, Yongliang Zhang, Zihai Li, 2016, Oncoimmunology.

Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer

L. Koniaris, M. Jordá, J. Slingerland, 2012, Breast Cancer Research and Treatment.

Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia.

Yixin Wang, S. Malek, M. McDevitt, 2012, Blood.

Comparison of SPECT/CT, SPECT, and Planar Imaging with Single- and Dual-Phase 99mTc-Sestamibi Parathyroid Scintigraphy

Harvey A. Ziessman, Martha A. Zeiger, J. Leal, 2007, Journal of Nuclear Medicine.

A Phase II Study of Imatinib Mesylate in Prostate Cancer Patients With Evidence of Biochemical Relapse Following Definitive Radical Retropubic Prostatectomy or Radiation Therapy

T. DeWeese, M. Carducci, W. Nelson, 2005 .

Immune chaperone gp96 drives the contributions of macrophages to inflammatory colon tumorigenesis.

Yongliang Zhang, Zihai Li, X. Ouyang, 2014, Cancer research.